Strong and nonspecific synergistic antibacterial/antibiofilm impact of nano-silver biosynthesized and decorated with active ingredients of Oscimum basilicum L.
Abstract In this study, Ocimum basilicum (a proven broad spectrum medicinal plant for broad-spectrum pharmacological activities) leaf extract was used as conjugates for the fabrication of silver nanoparticles (AgNP). Color change of the reaction mixture and UV–Visible spectrophotometry indicated the fabrication of silver nanoparticles, further X-ray diffraction (XRD) crystallography, scanning electron microscopy (SEM), transmission electron microscopic images (TEM), and Selected area electron diffraction (SAED) confirms the purity, monodispersity, and morphology including size (22.4 nm) and conjugated functional group of Ocimum basilicum. The conjugation of functional OH, N–O, and C=O groups was confirmed by Fourier-transform infrared spectroscopy (FT-IR). The engineered AgNP have shown significantly efficient antibacterial and antibiofilm activities (92.7% biofilm inhibition) on diverse clinical strains and thus showed its potential for use in clinical applications..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
3 Biotech - 11(2021), 4 vom: 03. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Muthulakshmi, Lakshmanan [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Antibacterial |
|---|
| Anmerkungen: |
© King Abdulaziz City for Science and Technology 2021 |
|---|
| doi: |
10.1007/s13205-021-02687-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2124152645 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2124152645 | ||
| 003 | DE-627 | ||
| 005 | 20230505093340.0 | ||
| 007 | tu | ||
| 008 | 230505s2021 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13205-021-02687-x |2 doi | |
| 035 | |a (DE-627)OLC2124152645 | ||
| 035 | |a (DE-He213)s13205-021-02687-x-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Muthulakshmi, Lakshmanan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Strong and nonspecific synergistic antibacterial/antibiofilm impact of nano-silver biosynthesized and decorated with active ingredients of Oscimum basilicum L. |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © King Abdulaziz City for Science and Technology 2021 | ||
| 520 | |a Abstract In this study, Ocimum basilicum (a proven broad spectrum medicinal plant for broad-spectrum pharmacological activities) leaf extract was used as conjugates for the fabrication of silver nanoparticles (AgNP). Color change of the reaction mixture and UV–Visible spectrophotometry indicated the fabrication of silver nanoparticles, further X-ray diffraction (XRD) crystallography, scanning electron microscopy (SEM), transmission electron microscopic images (TEM), and Selected area electron diffraction (SAED) confirms the purity, monodispersity, and morphology including size (22.4 nm) and conjugated functional group of Ocimum basilicum. The conjugation of functional OH, N–O, and C=O groups was confirmed by Fourier-transform infrared spectroscopy (FT-IR). The engineered AgNP have shown significantly efficient antibacterial and antibiofilm activities (92.7% biofilm inhibition) on diverse clinical strains and thus showed its potential for use in clinical applications. | ||
| 650 | 4 | |a Silver nanoparticles | |
| 650 | 4 | |a Pathogens | |
| 650 | 4 | |a Clinical microbiology | |
| 650 | 4 | |a Antibiofilm | |
| 650 | 4 | |a Antibacterial | |
| 700 | 1 | |a Vijayakumar, T. |4 aut | |
| 700 | 1 | |a Selvam, P. |4 aut | |
| 700 | 1 | |a Annaraj, J. |4 aut | |
| 700 | 1 | |a Ranjan, Shivendu |0 (orcid)0000-0001-6552-038X |4 aut | |
| 700 | 1 | |a Dasgupta, Nandita |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t 3 Biotech |d Springer International Publishing, 2013 |g 11(2021), 4 vom: 03. März |w (DE-627)1667343041 |w (DE-600)2974829-X |x 2190-572X |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g number:4 |g day:03 |g month:03 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s13205-021-02687-x |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2021 |e 4 |b 03 |c 03 | ||